4
Changes in Ownership
BIOGEN INC. Filed Acc 0001127602-20-028410
EVP, Research & Development sold 1,500 shares at $350.00 ($525,000)
From the SEC's structured data for this filing
Trades in this filing
Sandrock Alfred · EVP, Research & Development
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-04 | Sale : show line 1 in the form | −1,500 | $350.00 | $525,000 | 13,066.21 | D |
| Open-market sales · 1,500 sh · avg $350.00 · $525,000 | ||||||
Loading xslF345X03/form4.xml…